Department of Translational Medical Science, University of Naples Federico II, Italy
Casa di Cura San Michele, MaddaloniCE, Italy
Institute of Biostructure and Bioimaging, CNR, Naples, Italy
Italy SDN Foundation, Institute of Diagnostic and Nuclear Development, Naples, Italy
University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium
Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy
Department of Advanced Biomedical Science, University Federico II of Naples, Naples, Italy
University of Liege Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liege, Belgium.
References: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) (1994) Lancet, 334, pp. 1383-138
Sacks, F.M., Pfeffer, M.A., Moye, L.A., The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels (1996) N. Engl. J. Med., 335, pp. 1001-1009
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and broad range of initial cholesterol levels. The long-term intervention with pravastatin in Ischaemic disease (LIPID) study group (1998) N. Engl. J. Med., 339, pp. 1349-1357
West of Scotland coronary prevention study: identification of high-risk groups and comparison with other cardiovascular intervention trials (1996) Lancet, 346, pp. 1339-1342
Downs, J.R., Clearfield, M., Weis, S., Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels (1999) N. Engl. J. Med., 339, pp. 1615-1622
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., Bernini, F., New insights into the pharmacodynamic and pharmacokinetic properties of statins (1999) Pharmacol. Ther., 84, pp. 413-428
Rocha, V.Z., Libby, P., Obesity, inflammation, and atherosclerosis (2009) Nat. Rev. Cardiol., 6, pp. 399-409
Tedgui, A., Mallat, Z., Cytokines in atherosclerosis: pathogenic and regulatory pathways (2006) Physiol. Rev., 86, pp. 515-581
Parisi, V., Leosco, D., Ferro, G., Bevilacqua, A., Pagano, G., de Lucia, C., PerroneFilardi, P., Ferrara, N., The lipid theory in the pathogenesis of calcific aortic stenosis (2015) Nutr. Metab. Cardiovasc. Dis., 25, pp. 519-525
Saito, S., Fujiwara, T., Matsunaga, T., Minagawa, K., Fukui, K., Fukuda, I., Osanai, T., Okumura, K., Increased adiponectin synthesis in the visceral adipose tissue in men with coronary artery disease treated with pravastatin: a role of the attenuation of oxidative stress (2008) Atherosclerosis, 199, pp. 378-383
Łabuzek, K., Bułdak, Ł., Duława-Bułdak, A., Bielecka, A., Krysiak, R., Madej, A., Okopień, B., Atorvastatin and fenofibric acid differentially affect the release of adipokines in the visceral and subcutaneous cultures of adipocytes that were obtained from patients with and without mixed dyslipidemia (2011) Pharmacol. Rep., 63, pp. 1124-1136
Mazurek, T., Zhang, L., Zalewski, A., Mannion, J.D., Diehl, J.T., Arafat, H., Sarov-Blat, L., Shi, Y., Human epicardial adipose tissue is a source of inflammatory mediators (2003) Circulation, 108, pp. 2460-2466
Baker, A.R., Silva, N.F., Quinn, D.W., Harte, A.L., Pagano, D., Bonser, R.S., Kumar, S., McTernan, P.G., Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease (2006) Cardiovasc. Diabetol., 5, p. 1
Parisi, V., Rengo, G., Pagano, G., D'Esposito, V., Passaretti, F., Caruso, A., Grimaldi, M.G., Leosco, D., Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis (2015) Int. J. Cardiol., 186, pp. 167-169
Baumgartner, H., Falk, V., Bax, J.J., De Bonis, M., Hamm, C., Holm, P.J., Iung, B., ESC Scientific Document Group, 2017 ESC/EACTS guidelines for the management of valvular heart disease (2017) Eur. Heart J., 38, pp. 2739-2791
Royston, P., Ambler, G., Sauerbrei, W., The use of fractional polynomials to model continuous risk variables in epidemiology (1999) Int. J. Epidemiol., 28, pp. 964-974
Shorrocks, A.F., Decomposition procedures for distributional analysis: a unified framework based on the Shapley value (2013) J. Econ. Inequal., 11, pp. 99-126
Royston, P., Sauerbrei, W., Multivariate Model Building. A Pragmatic Approach to Regression Analysis Based On Fractional Polynomials for Modeling Continuous Variables (2008), pp. 183-186. , Wiley Chichester. UK
Kutner, M.H., Nachtsheim, C.J., Neter, J., Li, W., Applied Linear Statistical Models (2005), p. 409. , 5th edition McGraw Hill Irwin, New York. NY
Suleiman, A.A., Analysis of multicollinearity in multiple regressions (2015) Int. J. Adv. Technol. Eng. Sci., 3, pp. 571-578
Iacobellis, G., Ribaudo, M.C., Assael, F., Vecci, E., Tiberti, C., Zappaterreno, A., Di Mario, U., Leonetti, F., Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk (2003) J. Clin. Endocrinol. Metab., 88, p. 5163e8
Iacobellis, G., Leonetti, F., Epicardial adipose tissue and insulin resistance in obese subjects (2005) J. Clin. Endocrinol. Metab., 90, pp. 6300-6302
Ahn, S.G., Lim, H.S., Joe, D.Y., Kang, S.J., Choi, B.J., Choi, S.Y., Yoon, M.H., Shin, J.H., Relationship of epicardial adipose tissue by echocardiography to coronary artery disease (2008) Heart, 94, p. e7
Park, J.H., Park, Y.S., Kim, Y.J., Lee, I.S., Kim, J.H., Lee, J.H., Choi, S.W., Seong, I.W., Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe (2010) J. Cardiovasc. Ultrasound, 18, pp. 121-126
Soucek, F., Covassin, N., Singh, P., Ruzek, L., Kara, T., Suleiman, M., Lerman, A., Somers, V.K., Effects of atorvastatin (80 mg) therapy on quantity of epicardial adipose tissue in patients undergoing pulmonary vein isolation for atrial fibrillation (2015) Am. J. Cardiol., 116, pp. 1443-1446
Alexopoulos, N., Melek, B.H., Arepalli, C.D., Hartlage, G.R., Chen, Z., Kim, S., Stillman, A.E., Raggi, P., Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (beyond endorsed lipid lowering with EBT scanning) (2013) J. Am. Coll. Cardiol., 61, pp. 1956-1961
Abe, M., Matsuda, M., Kobayashi, H., Miyata, Y., Nakayama, Y., Komuro, R., Fukuhara, A., Shimomura, I., Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages (2008) Arterioscler. Thromb. Vasc. Biol., 28, pp. 871-877
Hartman, J., Frishman, W.H., Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy (2014) Cardiol. Rev., 22, pp. 147-151
Gualtero, D.F., Viafara-Garcia, S.M., Morantes, S.J., Buitrago, D.M., Gonzalez, O.A., Lafaurie, G.I., Rosuvastatin inhibits interleukin (IL)-8 and IL-6 production in human coronary artery endothelial cells stimulated with Aggregatibacter actinomycetemcomitans serotype b (2017) J. Periodontol., 88, pp. 225-235
Blyme, A., Asferg, C., Nielsen, O.W., Sehestedt, T., Kesäniemi, Y.A., Gohlke-Bärwolf, C., Boman, K., Olsen, M.H., High sensitivity C reactive protein as a prognostic marker in patients with mild moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy (2015) Open Heart, 2
Ridker, P.M., From C-Reactive Protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for atheroprotection (2016) Circ. Res., 118, pp. 145-156
Iacobellis, G., Willens, H.J., Echocardiographic epicardial fat: a review of research and clinical applications (2009) J. Am. Soc. Echocardiogr., 22, pp. 1311-1319
Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(297 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote
Testino G, Leone S, Fagoonee S, Del Bas JM, Rodriguez B, Puiggros F, Marine S, Rodriguez MA, Morina D, Armengol L, Caimari A, Arola L, Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-gentilucci U, Cavallo MG, Morini S, Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV, Lee SM, Jun DW, Cho YK, Jang KS, Kucukazman M, Ata N, Dal K, Yeniova AO, Kefeli A, Basyigit S, Aktas B, Akin KO, Agladioglu K, Ure OS, Topal F, Nazligul Y, Beyan E, Ertugrul DT, Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, Fallo F, Goto Y, Ray MB, Mendenhall CL, French SW, Gartside PS Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease(600 views) Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 1988 Sep; 83120693611123109(5): 1019-1026. Impact Factor:0.913 ViewExport to BibTeXExport to EndNote
65 Records (61 excluding Abstracts). Total impact factor: 317.249 (306.927 excluding Abstracts). Total 5 year impact factor: 250.06 (239.71 excluding Abstracts).